These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 11713262)

  • 1. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis.
    Krueger A; Baumann S; Krammer PH; Kirchhoff S
    Mol Cell Biol; 2001 Dec; 21(24):8247-54. PubMed ID: 11713262
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of the NF-kappaB pathway by caspase 8 and its homologs.
    Chaudhary PM; Eby MT; Jasmin A; Kumar A; Liu L; Hood L
    Oncogene; 2000 Sep; 19(39):4451-60. PubMed ID: 11002417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death.
    Han DK; Chaudhary PM; Wright ME; Friedman C; Trask BJ; Riedel RT; Baskin DG; Schwartz SM; Hood L
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11333-8. PubMed ID: 9326610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
    Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.
    Mathas S; Lietz A; Anagnostopoulos I; Hummel F; Wiesner B; Janz M; Jundt F; Hirsch B; Jöhrens-Leder K; Vornlocher HP; Bommert K; Stein H; Dörken B
    J Exp Med; 2004 Apr; 199(8):1041-52. PubMed ID: 15078899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins.
    Chaudhary PM; Jasmin A; Eby MT; Hood L
    Oncogene; 1999 Oct; 18(42):5738-46. PubMed ID: 10523854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis.
    Hentze H; Latta M; Künstle G; Dhakshinamoorthy S; Ng PY; Porter AG; Wendel A
    Hepatology; 2004 May; 39(5):1311-20. PubMed ID: 15122760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review).
    Gupta S
    Int J Oncol; 2003 Jan; 22(1):15-20. PubMed ID: 12469180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-FLICE inhibitory protein expression inhibits T-cell activation.
    Tai TS; Fang LW; Lai MZ
    Cell Death Differ; 2004 Jan; 11(1):69-79. PubMed ID: 12970675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
    Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
    Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Death receptors in chemotherapy and cancer.
    Debatin KM; Krammer PH
    Oncogene; 2004 Apr; 23(16):2950-66. PubMed ID: 15077156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of flice-inhibitory protein (FLIP) and NFkappaB is associated with death receptor-induced cell death in human aortic endothelial cells (HAECs).
    Okada Y; Kato M; Minakami H; Inoue Y; Morikawa A; Otsuki K; Kimura H
    Cytokine; 2001 Jul; 15(2):66-74. PubMed ID: 11500081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
    Zhang L; Fang B
    Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic regulation of Forkhead transcription factor FOXO3a by caspase-3-like proteases.
    Charvet C; Alberti I; Luciano F; Jacquel A; Bernard A; Auberger P; Deckert M
    Oncogene; 2003 Jul; 22(29):4557-68. PubMed ID: 12881712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Death receptors and melanoma resistance to apoptosis.
    Ivanov VN; Bhoumik A; Ronai Z
    Oncogene; 2003 May; 22(20):3152-61. PubMed ID: 12789291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the FLICE Inhibitory Protein (FLIP) in cancer therapy.
    Wajant H
    Mol Interv; 2003 May; 3(3):124-7. PubMed ID: 14993418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP.
    Kreuz S; Siegmund D; Rumpf JJ; Samel D; Leverkus M; Janssen O; Häcker G; Dittrich-Breiholz O; Kracht M; Scheurich P; Wajant H
    J Cell Biol; 2004 Aug; 166(3):369-80. PubMed ID: 15289496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.